Challenging the FDA black box warning for high aspirin dose with ticagrelor in patients with diabetes

James J. DiNicolantonio, Victor L. Serebruany

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Fingerprint

Dive into the research topics of 'Challenging the FDA black box warning for high aspirin dose with ticagrelor in patients with diabetes'. Together they form a unique fingerprint.

Medicine & Life Sciences